GWS
BEAM icon

Glassman Wealth Services’s Beam Therapeutics BEAM Stock Holding History

Glassman Wealth Services’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-120
Closed -$3.27K – 389
2023
Q4 		$3.27K Buy
120
+26
+28% +$646 ﹤0.01% 1194
2023
Q3 		$2.26K Buy
94
+89
+1,780% +$2.39K ﹤0.01% 1296
2023
Q2 		$160 Buy
+5
New +$162 ﹤0.01% 1852
2023
Q1 		– Sell
-3
Closed -$117 – 1904
2022
Q4 		$117 Hold
3
– – ﹤0.01% 1871
2022
Q3 		$0 Hold
3
– – ﹤0.01% 1663
2022
Q2 		$0 Sell
3
-11
-79% -$437 ﹤0.01% 1674
2022
Q1 		$1K Buy
+14
New +$918 ﹤0.01% 1332

Other funds holding BEAM

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Glassman Wealth Services's BEAM Position: Q1 2024 in Review

Glassman Wealth Services sold out of Beam Therapeutics (BEAM) in Q1 2024, closing a stake of 120 shares — an estimated $3.27K sold.

Glassman Wealth Services first reported a position in BEAM in Q1 2022 and held it in 7 quarters. The position peaked at $3.27K in Q4 2023. 221 funds tracked by Wall St. Rank hold BEAM as of Q1 2024.

  • Glassman Wealth Services reported no remaining Beam Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 120 Beam Therapeutics shares in Q1 2024, an estimated $3.27K.
  • Glassman Wealth Services first reported a position in Beam Therapeutics in Q1 2022 and held it in 7 quarters.
  • Glassman Wealth Services's Beam Therapeutics position peaked at $3.27K in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.